BLUM HOLDINGS, INC. (BLMH)

BLUM HOLDINGS, INC. (ticker BLMH, CIK 1996210) is a special-purpose acquisition company (SPAC) that raised capital through a blank-check public offering and is seeking to acquire an operating business. As a shell entity, BLUM has no commercial operations, only the interests and incentives of its sponsors and shareholders—which often conflict, creating structural agency problems that predate any actual merger.

Sponsor Incentives Misaligned with Public Shareholders

The fundamental risk of any SPAC is that its sponsors—the wealthy individuals or firms who organized it and committed capital—have financial incentives that diverge sharply from those of public shareholders who invested after the SPAC’s initial public offering. Sponsors earn “promote” shares (typically 20% of post-merger equity) at no cost if a merger is completed, meaning they profit regardless of whether the merged entity performs well. In contrast, public shareholders’ returns depend entirely on the post-merger company’s operating success.

This asymmetry creates a perverse incentive: sponsors are motivated to complete any deal that doesn’t trigger too many redemptions, not necessarily the best deal for public investors. BLUM’s sponsors have an inherent motivation to merge, and to do so at a price that maximizes their promote shares’ value rather than the returns to public holders. Public shareholders, meanwhile, have the right to redeem their shares if they disapprove of the proposed target—but redemption entitles them only to their pro-rata share of cash held in trust, which is typically less than the share’s pre-announcement price (often $9.50 to $10.00 per share for a $10 SPAC). This creates a “hold or lose money” dynamic that gives sponsors asymmetric negotiating power.

The Redemption Overhang and Deal Certainty

BLUM’s success—measured by whether it can complete a meaningful acquisition—depends on keeping public shareholders’ redemption rate below certain thresholds. If redemptions exceed the target company’s required capital, the deal may become uneconomical or impossible to complete. Sponsors and targets then engage in complex negotiations around earnouts, sponsor equity rolls, and additional financing to close the gap. These negotiations often result in deal structures that favor early insiders (sponsors and targets with favorable terms) at the expense of late-arriving public shareholders.

Additionally, the more popular SPAC investing becomes (attracting passive investors to SPACs as a asset class), the more likely that redemptions will be elevated—forcing sponsors to pursue deals at lower prices or with higher dilution to existing public shareholders to make the math work.

Governance and Transparency Gaps

As a shell company before merger, BLUM has minimal business operations and thus limited transparency requirements. Its 10-K filing will describe its SPAC structure, the capital raised, and the identity of sponsors and their financial interests, but it does not reveal what business BLUM intends to acquire. This information asymmetry persists until a merger target is announced—meaning public shareholders must decide whether to redeem based on confidence in the sponsors’ judgment and track record, not on concrete information about the target.

Once a merger target is announced, shareholders receive a proxy statement with financial projections provided by the target company (not independently audited). SPAC targets often provide overly optimistic projections to justify their pre-merger valuation; public shareholders have limited ability to conduct diligence, and they vote on whether to approve the deal in a compressed timeframe. If projections prove wildly inaccurate post-merger, shareholders have little recourse: the target’s founders and earlier investors have already locked in their gains, and suing for securities fraud is expensive and uncertain.

Capitalization and Dilution Risk

BLUM went public with a specific amount of capital (typically $150–$500 million for SPAC trusts of this era). However, by the time a merger is negotiated, that capital may be insufficient to complete the deal and fund the target’s operations. Sponsors then must secure additional financing—either from anchor investors, outside banks, or the sponsors themselves. This additional financing typically comes with dilution to public shareholders, either through the issue of new equity or through warrants that are exercised later.

Warrants, in particular, represent a hidden dilution risk. BLUM issued warrants as part of its original SPAC offering, and these warrants will be exercised if the merged entity’s stock price rises above a certain threshold. When warrants are exercised, public shareholders are diluted—their ownership stake shrinks, and their earnings-per-share metric deteriorates. The dilution from warrant exercises can be substantial in a high-performing post-merger company, offsetting public shareholders’ gains in stock price.

Business Model and Revenue Uncertainty

Because BLUM is a shell, its post-merger economics are entirely unknown. The target company could be in any sector, at any stage of maturity, with any business model. This unpredictability makes BLUM suitable only for investors with high risk tolerance or strong conviction in the sponsors’ ability to source exceptional targets. Public shareholders who invest in BLUM are not buying a business; they are buying a bet on the sponsors’ deal-sourcing and negotiation skills. If the sponsors’ track record is unproven or mixed, that risk is uncompensated.

The Regulatory and Structural Sunset

SPACs are a time-limited structure: if a merger is not completed within a specified window (typically 18–24 months, sometimes extended), the SPAC must liquidate and return capital to shareholders. This artificial deadline creates pressure to complete a deal hastily, even if negotiating for better terms would benefit shareholders. BLUM’s ability to complete a transaction before any extension expires is a critical milestone, and any regulatory changes affecting SPAC rules (as the SEC has proposed) could alter the timeline or the cost of operating the SPAC during the window.